EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Is a full psychotherapy program necessary to reduce benzodiazepine dependence for insomnia? A Randomized Controlled Trial Comparing Drug Tapering with Single-Session CBT vs. Full Acceptance and Commitment Therapy

Mélinée Chapoutot, Marie-Paule Gustin, Royce Anders, Laure Peter-Derex, Hélène Bastuji, Yasser Khazaal, Benjamin Putois

Sleep Medicine · 2026

DOI: 10.1016/j.sleep.2025.108744 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Sleep Medicine, 2026. Verfasst von Mélinée Chapoutot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sleep Center, CHVR, Av. du Grand-Champsec 80, 1951, Sion, Switzerland; Lyon Neuroscience Research Center, CNRS UMR 5292 - INSERM U1028 - Lyon 1 Unive…. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Cognitive Behavioral Therapy, Benzodiazepines, Acceptance and Commitment Therapy. Die Arbeit nennt 91 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Benzodiazepines and Z-drugs (BZs) are known to present a high-risk for chronic dependence when patients do not adhere to duration of use guidelines. Cognitive Behavioral Therapy for Insomnia (CBT-I) has shown effectiveness to reduce dependence, but is not frequently sought by consumers due to being costly and time intensive. A single session of CBT-I may show promise as a compromise. The efficacy of these two approaches is herein compared in the context of a drug tapering program. METHOD: In this randomized controlled trial, the latest generation of CBT-I, Acceptance and Commitment Therapy for Insomnia (ACT-I), was compared to a single session of CBT-I in the context of a tapering program assessing two tapering speeds (rapid-6 weeks vs. long-18 weeks), and short vs. long BZs drug half-lives. The taper program consisted of 10-min phone guided sessions with a psychologist. Participants were evaluated pre-treatment, and at 1, 3, and 12 months post-treatment. RESULTS: Across all experimental groups, by 12 months, 58.6 % of the 87 participants achieved successful abstinence, and 29.9 % reduced their daily dosage by more than 50 %. No significant difference was observed between ACT-I and the single session of CBT-I. The rapid taper condition led to cumulative withdrawal symptoms in long BZ half-life consumers. CONCLUSION: Both ACT-I and the single session of CBT-I are associated with similar success rates when combined with a drug tapering program consisting of periodic telephone consultations. Clinical practice may be reevaluated to propose slow tapering for long BZ half-lives. The data show this program to be effective to a broad population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Initiation and Maintenance DisordersCognitive Behavioral TherapyBenzodiazepinesAcceptance and Commitment TherapySubstance-Related DisordersDrug TaperingHumansMaleFemaleAdultMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

Acceptance and Commitment TherapyAlternative protocolsBenzodiazepineCognitive Behavioral TherapyDependenceInsomniaTapering

Substanzen

Benzodiazepines

Autor:innen und Institutionen

  • Sleep Center, CHVR, Av. du Grand-Champsec 80, 1951, Sion, Switzerland; Lyon Neuroscience Research Center, CNRS UMR 5292 - INSERM U1028 - Lyon 1 University, 95 Bd Pinel, 69500, Bron, France. Electronic address: Melinee.C…
  • Public Health, Epidemiology and Evolutionary Ecology of Infectious Diseases (PHE3ID), International Centre for Infectiology Research (CIRI), INSERM U1111, CNRS UMR5308, ENS Lyon, Lyon, France; Institute of Pharmaceutic…
  • Univ Paul Valéry Montpellier 3, Univ. Montpellier, EPSYLON EA 4556, Rte de Mende, F34000, Montpellier, France. Electronic address: royce.anders@univ-montp3.fr.
  • Lyon Neuroscience Research Center, CNRS UMR 5292 - INSERM U1028 - Lyon 1 University, 95 Bd Pinel, 69500, Bron, France; Sleep Medicine and Respiratory Disease Center, Croix-Rousse Hospital, CHU of Lyon, 103 Gd Rue de la…
  • Addiction Medication Department, CHUV, Rue du Bugnon 23, 1005, Lausanne, Switzerland. Electronic address: Yasser.Khazaal@chuv.ch.
  • Lyon Neuroscience Research Center, CNRS UMR 5292 - INSERM U1028 - Lyon 1 University, 95 Bd Pinel, 69500, Bron, France; Faculty of Psychology, UniDistance Suisse, 3900, Brig, Switzerland. Electronic address: benjamin.put…

Zitieren

APA

Chapoutot, M., Gustin, M. P., Anders, R., Peter-Derex, L., Bastuji, H., Khazaal, Y., & Putois, B. (2026). Is a full psychotherapy program necessary to reduce benzodiazepine dependence for insomnia? A Randomized Controlled Trial Comparing Drug Tapering with Single-Session CBT vs. Full Acceptance and Commitment Therapy. Sleep Medicine. https://doi.org/10.1016/j.sleep.2025.108744

Vancouver

Chapoutot M, Gustin MP, Anders R, Peter-Derex L, Bastuji H, Khazaal Y, et al. Is a full psychotherapy program necessary to reduce benzodiazepine dependence for insomnia? A Randomized Controlled Trial Comparing Drug Tapering with Single-Session CBT vs. Full Acceptance and Commitment Therapy. Sleep Medicine. 2026. doi:10.1016/j.sleep.2025.108744

BibTeX
@article{Chapoutot2026,
  author = {Chapoutot, Mélinée and Gustin, Marie-Paule and Anders, Royce and Peter-Derex, Laure and Bastuji, Hélène and Khazaal, Yasser and Putois, Benjamin},
  title = {Is a full psychotherapy program necessary to reduce benzodiazepine dependence for insomnia? A Randomized Controlled Trial Comparing Drug Tapering with Single-Session CBT vs. Full Acceptance and Commitment Therapy},
  journal = {Sleep Medicine},
  year = {2026},
  doi = {10.1016/j.sleep.2025.108744}
}
Kostenlos starten →